-
1
-
-
0035856980
-
Biochemistry and molecular cell biology of diabetic complications
-
Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414(6865):813-820.
-
(2001)
Nature
, vol.414
, Issue.6865
, pp. 813-820
-
-
Brownlee, M.1
-
2
-
-
0036167208
-
Diabetes and advanced glycation endproducts
-
Vlassara H, Palace MR. Diabetes and advanced glycation endproducts. J Intern Med 2002;251(2):87-101.
-
(2002)
J Intern Med
, vol.251
, Issue.2
, pp. 87-101
-
-
Vlassara, H.1
Palace, M.R.2
-
3
-
-
0000916315
-
Action des acides amines sur les sucre: formation des melanoidines par voie methodique
-
Maillard L. Action des acides amines sur les sucre: formation des melanoidines par voie methodique. C R Hebd Seances Acad Sci 1912;154:66-68.
-
(1912)
C R Hebd Seances Acad Sci
, vol.154
, pp. 66-68
-
-
Maillard, L.1
-
4
-
-
42449109476
-
Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications
-
Yan SF, Ramasamy R, Schmidt AM. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Nature clinical practice Endocrinol Metab 2008;4(5):285-293.
-
(2008)
Nature clinical practice Endocrinol Metab
, vol.4
, Issue.5
, pp. 285-293
-
-
Yan, S.F.1
Ramasamy, R.2
Schmidt, A.M.3
-
5
-
-
23744447530
-
Dicarbonyl intermediates in the maillard reaction
-
Thornalley PJ. Dicarbonyl intermediates in the maillard reaction. Ann N Y Acad Sci 2005;1043:111-117.
-
(2005)
Ann N Y Acad Sci
, vol.1043
, pp. 111-117
-
-
Thornalley, P.J.1
-
6
-
-
0027396022
-
The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal
-
Phillips SA, Thornalley PJ. The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. Eur J Biochem 1993;212(1):101-105.
-
(1993)
Eur J Biochem
, vol.212
, Issue.1
, pp. 101-105
-
-
Phillips, S.A.1
Thornalley, P.J.2
-
7
-
-
0021471746
-
Acid-base catalysis of the elimination and isomerization reactions of triose phosphates
-
Richard JP. Acid-base catalysis of the elimination and isomerization reactions of triose phosphates. J Am Chem Soc 1984;106(17):4926-4936.
-
(1984)
J Am Chem Soc
, vol.106
, Issue.17
, pp. 4926-4936
-
-
Richard, J.P.1
-
8
-
-
0037093336
-
Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified albumin
-
Ahmed N, Argirov OK, Minhas HS, Cordeiro CA, Thornalley PJ. Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified albumin. Biochem J 2002;364(Pt 1):1-14.
-
(2002)
Biochem J
, vol.364
, pp. 1-14
-
-
Ahmed, N.1
Argirov, O.K.2
Minhas, H.S.3
Cordeiro, C.A.4
Thornalley, P.J.5
-
9
-
-
0037093522
-
Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence
-
Ahmed N, Thornalley PJ. Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence. Biochem J 2002;364(Pt 1):15-24.
-
(2002)
Biochem J
, vol.364
, pp. 15-24
-
-
Ahmed, N.1
Thornalley, P.J.2
-
10
-
-
0033603599
-
Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts
-
Oya T, Hattori N, Mizuno Y, et al. Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. J Biol Chem 1999;274(26):18492-18502.
-
(1999)
J Biol Chem
, vol.274
, Issue.26
, pp. 18492-18502
-
-
Oya, T.1
Hattori, N.2
Mizuno, Y.3
-
11
-
-
0031214523
-
Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct
-
Shipanova IN, Glomb MA, Nagaraj RH. Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct. Arch Biochem Biophys 1997;344(1):29-36.
-
(1997)
Arch Biochem Biophys
, vol.344
, Issue.1
, pp. 29-36
-
-
Shipanova, I.N.1
Glomb, M.A.2
Nagaraj, R.H.3
-
12
-
-
0030919275
-
N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins
-
Ahmed MU, Brinkmann Frye E, Degenhardt TP, Thorpe SR, Baynes JW. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 1997;324 (Pt 2):565-570.
-
(1997)
Biochem J
, vol.324
, pp. 565-570
-
-
Ahmed, M.U.1
Brinkmann Frye, E.2
Degenhardt, T.P.3
Thorpe, S.R.4
Baynes, J.W.5
-
13
-
-
0032563120
-
Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins
-
Frye EB, Degenhardt TP, Thorpe SR, Baynes JW. Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins. J Biol Chem 1998;273(30):18714-18719.
-
(1998)
J Biol Chem
, vol.273
, Issue.30
, pp. 18714-18719
-
-
Frye, E.B.1
Degenhardt, T.P.2
Thorpe, S.R.3
Baynes, J.W.4
-
14
-
-
53849092368
-
Dicarbonyls linked to damage in the powerhouse: glycation of mitochondrial proteins and oxidative stress
-
Rabbani N, Thornalley PJ. Dicarbonyls linked to damage in the powerhouse: glycation of mitochondrial proteins and oxidative stress. Biochem Soc Trans 2008;36(Pt 5):1045-1050.
-
(2008)
Biochem Soc Trans
, vol.36
, pp. 1045-1050
-
-
Rabbani, N.1
Thornalley, P.J.2
-
15
-
-
0033571012
-
Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose
-
Thornalley PJ, Langborg A, Minhas HS. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 1999;344 Pt 1:109-116.
-
(1999)
Biochem J
, vol.344
, pp. 109-116
-
-
Thornalley, P.J.1
Langborg, A.2
Minhas, H.S.3
-
16
-
-
84879026126
-
The glyoxalase pathway: the first hundred years... and beyond
-
Sousa Silva M, Gomes RA, Ferreira AE, Ponces Freire A, Cordeiro C. The glyoxalase pathway: the first hundred years... and beyond. Biochem J 2013;453(1):1-15.
-
(2013)
Biochem J
, vol.453
, Issue.1
, pp. 1-15
-
-
Sousa Silva, M.1
Gomes, R.A.2
Ferreira, A.E.3
Ponces Freire, A.4
Cordeiro, C.5
-
17
-
-
0014217148
-
Alpha-keto aldehyde dehydrogenase, an enzyme that catalyzes the enzymic oxidation of methylglyoxal to pyruvate
-
Monder C. Alpha-keto aldehyde dehydrogenase, an enzyme that catalyzes the enzymic oxidation of methylglyoxal to pyruvate. J Biol Chem 1967;242(20):4603-4609.
-
(1967)
J Biol Chem
, vol.242
, Issue.20
, pp. 4603-4609
-
-
Monder, C.1
-
18
-
-
0026646131
-
Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications
-
Vander Jagt DL, Robinson B, Taylor KK, Hunsaker LA. Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications. J Biol Chem 1992;267(7):4364-4369.
-
(1992)
J Biol Chem
, vol.267
, Issue.7
, pp. 4364-4369
-
-
Vander Jagt, D.L.1
Robinson, B.2
Taylor, K.K.3
Hunsaker, L.A.4
-
19
-
-
0031847669
-
Methylglyoxal as substrate and inhibitor of human aldehyde dehydrogenase: comparison of kinetic properties among the three isozymes
-
Izaguirre G, Kikonyogo A, Pietruszko R. Methylglyoxal as substrate and inhibitor of human aldehyde dehydrogenase: comparison of kinetic properties among the three isozymes. Comp Biochem Physiol B Biochem Mol Biol 1998;119(4):747-754.
-
(1998)
Comp Biochem Physiol B Biochem Mol Biol
, vol.119
, Issue.4
, pp. 747-754
-
-
Izaguirre, G.1
Kikonyogo, A.2
Pietruszko, R.3
-
20
-
-
84901052694
-
ROS function in redox signaling and oxidative stress
-
Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol 2014;24(10):R453-462.
-
(2014)
Curr Biol
, vol.24
, Issue.10
, pp. R453-R462
-
-
Schieber, M.1
Chandel, N.S.2
-
21
-
-
0030498053
-
Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions
-
Requena JR, Fu MX, Ahmed MU, Jenkins AJ, Lyons TJ, Thorpe SR. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11(Suppl 5):48-53.
-
(1996)
Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association
, vol.11
, pp. 48-53
-
-
Requena, J.R.1
Fu, M.X.2
Ahmed, M.U.3
Jenkins, A.J.4
Lyons, T.J.5
Thorpe, S.R.6
-
22
-
-
0022480624
-
Kinetic analysis of glycation as a tool for assessing the half-life of proteins
-
Schleicher E, Wieland OH. Kinetic analysis of glycation as a tool for assessing the half-life of proteins. Biochim Biophys Act 1986;884(1):199-205.
-
(1986)
Biochim Biophys Act
, vol.884
, Issue.1
, pp. 199-205
-
-
Schleicher, E.1
Wieland, O.H.2
-
23
-
-
0023664488
-
Effect of phosphate on the kinetics and specificity of glycation of protein
-
Watkins NG, Neglia-Fisher CI, Dyer DG, Thorpe SR, Baynes JW. Effect of phosphate on the kinetics and specificity of glycation of protein. J Biol Chem 1987;262(15):7207-7212.
-
(1987)
J Biol Chem
, vol.262
, Issue.15
, pp. 7207-7212
-
-
Watkins, N.G.1
Neglia-Fisher, C.I.2
Dyer, D.G.3
Thorpe, S.R.4
Baynes, J.W.5
-
24
-
-
84911423174
-
The prevalence of Parkinson's disease: a systematic review and meta-analysis
-
Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord 2014;29(13):1583-1590.
-
(2014)
Mov Disord
, vol.29
, Issue.13
, pp. 1583-1590
-
-
Pringsheim, T.1
Jette, N.2
Frolkis, A.3
Steeves, T.D.4
-
25
-
-
0037333666
-
Staging of brain pathology related to sporadic Parkinson's disease
-
Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24(2):197-211.
-
(2003)
Neurobiol Aging
, vol.24
, Issue.2
, pp. 197-211
-
-
Braak, H.1
Del Tredici, K.2
Rub, U.3
de Vos, R.A.4
Jansen Steur, E.N.5
Braak, E.6
-
26
-
-
0032568534
-
alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies
-
Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A 1998;95(11):6469-6473.
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, Issue.11
, pp. 6469-6473
-
-
Spillantini, M.G.1
Crowther, R.A.2
Jakes, R.3
Hasegawa, M.4
Goedert, M.5
-
27
-
-
10544234193
-
Mapping of a gene for Parkinson's disease to chromosome 4q21-q23
-
Polymeropoulos MH, Higgins JJ, Golbe LI, et al. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 1996;274(5290):1197-1199.
-
(1996)
Science
, vol.274
, Issue.5290
, pp. 1197-1199
-
-
Polymeropoulos, M.H.1
Higgins, J.J.2
Golbe, L.I.3
-
28
-
-
0029981526
-
Neuropathology of Parkinson's disease
-
Forno LS. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 1996;55(3):259-272.
-
(1996)
J Neuropathol Exp Neurol
, vol.55
, Issue.3
, pp. 259-272
-
-
Forno, L.S.1
-
29
-
-
32544432029
-
Non-motor symptoms of Parkinson's disease: diagnosis and management
-
National Institute for Clinical E
-
Chaudhuri KR, Healy DG, Schapira AH, National Institute for Clinical E. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5(3):235-245.
-
(2006)
Lancet Neurol
, vol.5
, Issue.3
, pp. 235-245
-
-
Chaudhuri, K.R.1
Healy, D.G.2
Schapira, A.H.3
-
30
-
-
84858046578
-
Neuropathological alterations in Alzheimer disease
-
Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 2011;1(1):a006189.
-
(2011)
Cold Spring Harb Perspect Med
, vol.1
, Issue.1
, pp. a006189
-
-
Serrano-Pozo, A.1
Frosch, M.P.2
Masliah, E.3
Hyman, B.T.4
-
31
-
-
84872551783
-
Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration
-
Wang JZ, Xia YY, Grundke-Iqbal I, Iqbal K. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. J Alzheimers Dis 2013;33(Suppl 1):S123-139.
-
(2013)
J Alzheimers Dis
, vol.33
, pp. S123-S139
-
-
Wang, J.Z.1
Xia, Y.Y.2
Grundke-Iqbal, I.3
Iqbal, K.4
-
32
-
-
75149136696
-
Alzheimer's disease and the amyloid-beta peptide
-
Murphy MP, LeVine H 3rd. Alzheimer's disease and the amyloid-beta peptide. J Alzheimers Dis 2010;19(1):311-323.
-
(2010)
J Alzheimers Dis
, vol.19
, Issue.1
, pp. 311-323
-
-
Murphy, M.P.1
LeVine, H.2
-
33
-
-
84878534880
-
Altered serum IgG levels to alpha-synuclein in dementia with Lewy bodies and Alzheimer's disease
-
Koehler NK, Stransky E, Shing M, et al. Altered serum IgG levels to alpha-synuclein in dementia with Lewy bodies and Alzheimer's disease. PLoS One 2013;8(5):e64649.
-
(2013)
PLoS One
, vol.8
, Issue.5
, pp. e64649
-
-
Koehler, N.K.1
Stransky, E.2
Shing, M.3
-
34
-
-
84893652011
-
Effects of baseline CSF alpha-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease
-
Mattsson N, Insel P, Tosun D, et al. Effects of baseline CSF alpha-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease. PLoS One 2013;8(12):e85443.
-
(2013)
PLoS One
, vol.8
, Issue.12
, pp. e85443
-
-
Mattsson, N.1
Insel, P.2
Tosun, D.3
-
35
-
-
0342514665
-
Plaque-associated alpha-synuclein (NACP) pathology in aged transgenic mice expressing amyloid precursor protein
-
Yang F, Ueda K, Chen P, Ashe KH, Cole GM. Plaque-associated alpha-synuclein (NACP) pathology in aged transgenic mice expressing amyloid precursor protein. Brain Res 2000;853(2):381-383.
-
(2000)
Brain Res
, vol.853
, Issue.2
, pp. 381-383
-
-
Yang, F.1
Ueda, K.2
Chen, P.3
Ashe, K.H.4
Cole, G.M.5
-
36
-
-
84881424881
-
Alzheimer's Disease Neuroimaging I. alpha-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment
-
Korff A, Liu C, Ginghina C, Shi M, Zhang J, Alzheimer's Disease Neuroimaging I. alpha-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment. J Alzheimers Dis 2013;36(4):679-688.
-
(2013)
J Alzheimers Dis
, vol.36
, Issue.4
, pp. 679-688
-
-
Korff, A.1
Liu, C.2
Ginghina, C.3
Shi, M.4
Zhang, J.5
-
37
-
-
84885699313
-
Association of cerebrospinal fluid beta-amyloid 1-42, T-tau, P-tau181, and alpha-synuclein levels with clinical features of drug-naive patients with early Parkinson disease
-
Kang JH, Irwin DJ, Chen-Plotkin AS, et al. Association of cerebrospinal fluid beta-amyloid 1-42, T-tau, P-tau181, and alpha-synuclein levels with clinical features of drug-naive patients with early Parkinson disease. JAMA Neurol 2013;70(10):1277-1287.
-
(2013)
JAMA Neurol
, vol.70
, Issue.10
, pp. 1277-1287
-
-
Kang, J.H.1
Irwin, D.J.2
Chen-Plotkin, A.S.3
-
39
-
-
36249019041
-
Prospective study of dietary pattern and risk of Parkinson disease
-
Gao X, Chen H, Fung TT, et al. Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr 2007;86(5):1486-1494.
-
(2007)
Am J Clin Nutr
, vol.86
, Issue.5
, pp. 1486-1494
-
-
Gao, X.1
Chen, H.2
Fung, T.T.3
-
40
-
-
84925794942
-
Observational and ecological studies of dietary advanced glycation end products in national diets and Alzheimer's disease incidence and prevalence
-
Perrone L, Grant WB. Observational and ecological studies of dietary advanced glycation end products in national diets and Alzheimer's disease incidence and prevalence. J Alzheimers Dis 2015;45(3):965-979.
-
(2015)
J Alzheimers Dis
, vol.45
, Issue.3
, pp. 965-979
-
-
Perrone, L.1
Grant, W.B.2
-
41
-
-
0039267710
-
Progression and prognosis in Parkinson's disease
-
Schwab RS. Progression and prognosis in Parkinson's disease. J Nerv Ment Dis 1960;130:556-566.
-
(1960)
J Nerv Ment Dis
, vol.130
, pp. 556-566
-
-
Schwab, R.S.1
-
42
-
-
34548206868
-
[Clinical experience with tolbutamide in Parkinson's disease]
-
Barbeau A, Giguere R, Hardy J. [Clinical experience with tolbutamide in Parkinson's disease]. Union Med Can 1961;90:147-151.
-
(1961)
Union Med Can
, vol.90
, pp. 147-151
-
-
Barbeau, A.1
Giguere, R.2
Hardy, J.3
-
43
-
-
0016318795
-
Glucose intolerance in Parkinson's disease
-
Lipman IJ, Boykin ME, Flora RE. Glucose intolerance in Parkinson's disease. J Chron Dis 1974;27(11-12):573-579.
-
(1974)
J Chron Dis
, vol.27
, Issue.11-12
, pp. 573-579
-
-
Lipman, I.J.1
Boykin, M.E.2
Flora, R.E.3
-
44
-
-
0027561888
-
The relationship between diabetes mellitus and Parkinson's disease
-
Sandyk R. The relationship between diabetes mellitus and Parkinson's disease. Int J Neurosci 1993;69(1-4):125-130.
-
(1993)
Int J Neurosci
, vol.69
, Issue.1-4
, pp. 125-130
-
-
Sandyk, R.1
-
45
-
-
0015145828
-
Endocrine function and glucose metabolism in patients with Parkinson's disease and their alternation by L-dopa
-
Boyd AE, 3rd, Lebovitz HE, Feldman JM. Endocrine function and glucose metabolism in patients with Parkinson's disease and their alternation by L-dopa. J Clin Endocrinol Metab 1971;33(5):829-837.
-
(1971)
J Clin Endocrinol Metab
, vol.33
, Issue.5
, pp. 829-837
-
-
Boyd, A.E.1
Lebovitz, H.E.2
Feldman, J.M.3
-
46
-
-
34147190028
-
Type 2 diabetes and the risk of Parkinson's disease
-
Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J. Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 2007;30(4):842-847.
-
(2007)
Diabetes Care
, vol.30
, Issue.4
, pp. 842-847
-
-
Hu, G.1
Jousilahti, P.2
Bidel, S.3
Antikainen, R.4
Tuomilehto, J.5
-
47
-
-
79956218430
-
Diabetes and risk of Parkinson's disease
-
Xu Q, Park Y, Huang X, et al. Diabetes and risk of Parkinson's disease. Diabetes Care 2011;34(4):910-915.
-
(2011)
Diabetes Care
, vol.34
, Issue.4
, pp. 910-915
-
-
Xu, Q.1
Park, Y.2
Huang, X.3
-
48
-
-
34249951771
-
Diabetes and parkinsonian signs in older persons
-
Arvanitakis Z, Wilson RS, Bienias JL, Bennett DA. Diabetes and parkinsonian signs in older persons. Alzheimer Dis Assoc Disord 2007;21(2):144-149.
-
(2007)
Alzheimer Dis Assoc Disord
, vol.21
, Issue.2
, pp. 144-149
-
-
Arvanitakis, Z.1
Wilson, R.S.2
Bienias, J.L.3
Bennett, D.A.4
-
49
-
-
84863625218
-
Clinical features of Parkinson disease when onset of diabetes came first: A case-control study
-
Cereda E, Barichella M, Cassani E, Caccialanza R, Pezzoli G. Clinical features of Parkinson disease when onset of diabetes came first: A case-control study. Neurology 2012;78(19):1507-1511.
-
(2012)
Neurology
, vol.78
, Issue.19
, pp. 1507-1511
-
-
Cereda, E.1
Barichella, M.2
Cassani, E.3
Caccialanza, R.4
Pezzoli, G.5
-
50
-
-
56149114786
-
Diabetes in patients with idiopathic Parkinson's disease
-
Becker C, Brobert GP, Johansson S, Jick SS, Meier CR. Diabetes in patients with idiopathic Parkinson's disease. Diabetes Care 2008;31(9):1808-1812.
-
(2008)
Diabetes Care
, vol.31
, Issue.9
, pp. 1808-1812
-
-
Becker, C.1
Brobert, G.P.2
Johansson, S.3
Jick, S.S.4
Meier, C.R.5
-
51
-
-
84859049352
-
Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis
-
Cereda E, Barichella M, Pedrolli C, et al. Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis. Diabetes Care 2011;34(12):2614-2623.
-
(2011)
Diabetes Care
, vol.34
, Issue.12
, pp. 2614-2623
-
-
Cereda, E.1
Barichella, M.2
Pedrolli, C.3
-
52
-
-
56149110407
-
Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease
-
Driver JA, Smith A, Buring JE, Gaziano JM, Kurth T, Logroscino G. Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 2008;31(10):2003-2005.
-
(2008)
Diabetes Care
, vol.31
, Issue.10
, pp. 2003-2005
-
-
Driver, J.A.1
Smith, A.2
Buring, J.E.3
Gaziano, J.M.4
Kurth, T.5
Logroscino, G.6
-
53
-
-
84908160592
-
Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies
-
Lu L, Fu DL, Li HQ, Liu AJ, Li JH, Zheng GQ. Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies. PLoS One 2014;9(1):e85781.
-
(2014)
PLoS One
, vol.9
, Issue.1
, pp. e85781
-
-
Lu, L.1
Fu, D.L.2
Li, H.Q.3
Liu, A.J.4
Li, J.H.5
Zheng, G.Q.6
-
54
-
-
84855830535
-
Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics)
-
Uchiki T, Weikel KA, Jiao W, et al. Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics). Aging Cell 2012;11(1):1-13.
-
(2012)
Aging Cell
, vol.11
, Issue.1
, pp. 1-13
-
-
Uchiki, T.1
Weikel, K.A.2
Jiao, W.3
-
55
-
-
0030459456
-
High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils
-
Ikemoto S, Takahashi M, Tsunoda N, Maruyama K, Itakura H, Ezaki O. High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils. Metab Clin Exp 1996;45(12):1539-1546.
-
(1996)
Metab Clin Exp
, vol.45
, Issue.12
, pp. 1539-1546
-
-
Ikemoto, S.1
Takahashi, M.2
Tsunoda, N.3
Maruyama, K.4
Itakura, H.5
Ezaki, O.6
-
56
-
-
0028961355
-
High fat diet-induced hyperglycemia: prevention by low level expression of a glucose transporter (GLUT4) minigene in transgenic mice
-
Ikemoto S, Thompson KS, Takahashi M, Itakura H, Lane MD, Ezaki O. High fat diet-induced hyperglycemia: prevention by low level expression of a glucose transporter (GLUT4) minigene in transgenic mice. Proc Natl Acad Sci U S A 1995;92(8):3096-3099.
-
(1995)
Proc Natl Acad Sci U S A
, vol.92
, Issue.8
, pp. 3096-3099
-
-
Ikemoto, S.1
Thompson, K.S.2
Takahashi, M.3
Itakura, H.4
Lane, M.D.5
Ezaki, O.6
-
57
-
-
77957575432
-
Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet
-
Morris JK, Bomhoff GL, Stanford JA, Geiger PC. Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet. Am J Physiol Regul Integr Comp Physiol 2010;299(4):R1082-1090.
-
(2010)
Am J Physiol Regul Integr Comp Physiol
, vol.299
, Issue.4
, pp. R1082-R1090
-
-
Morris, J.K.1
Bomhoff, G.L.2
Stanford, J.A.3
Geiger, P.C.4
-
58
-
-
13844275515
-
Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity
-
Choi JY, Jang EH, Park CS, Kang JH. Enhanced susceptibility to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity. Free Radic Biol Med 2005;38(6):806-816.
-
(2005)
Free Radic Biol Med
, vol.38
, Issue.6
, pp. 806-816
-
-
Choi, J.Y.1
Jang, E.H.2
Park, C.S.3
Kang, J.H.4
-
59
-
-
84918804167
-
Diet-induced obesity accelerates the onset of terminal phenotypes in alpha-synuclein transgenic mice
-
Rotermund C, Truckenmuller FM, Schell H, Kahle PJ. Diet-induced obesity accelerates the onset of terminal phenotypes in alpha-synuclein transgenic mice. J Neurochem 2014;131(6):848-858.
-
(2014)
J Neurochem
, vol.131
, Issue.6
, pp. 848-858
-
-
Rotermund, C.1
Truckenmuller, F.M.2
Schell, H.3
Kahle, P.J.4
-
60
-
-
34948816643
-
Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes
-
Han Y, Randell E, Vasdev S, et al. Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes. Mol Cell Biochem 2007;305(1-2):123-131.
-
(2007)
Mol Cell Biochem
, vol.305
, Issue.1-2
, pp. 123-131
-
-
Han, Y.1
Randell, E.2
Vasdev, S.3
-
61
-
-
0028292698
-
Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications
-
McLellan AC, Thornalley PJ, Benn J, Sonksen PH. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sc 1994;87(1):21-29.
-
(1994)
Clin Sc
, vol.87
, Issue.1
, pp. 21-29
-
-
McLellan, A.C.1
Thornalley, P.J.2
Benn, J.3
Sonksen, P.H.4
-
62
-
-
35248894440
-
Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitus
-
Wang H, Meng QH, Gordon JR, Khandwala H, Wu L. Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitus. Clin Biochem 2007;40(16-17):1232-1239.
-
(2007)
Clin Biochem
, vol.40
, Issue.16-17
, pp. 1232-1239
-
-
Wang, H.1
Meng, Q.H.2
Gordon, J.R.3
Khandwala, H.4
Wu, L.5
-
63
-
-
84883786992
-
Increased methylglyoxal formation with upregulation of renin angiotensin system in fructose fed Sprague Dawley rats
-
Dhar I, Dhar A, Wu L, Desai KM. Increased methylglyoxal formation with upregulation of renin angiotensin system in fructose fed Sprague Dawley rats. PLoS One 2013;8(9):e74212.
-
(2013)
PLoS One
, vol.8
, Issue.9
, pp. e74212
-
-
Dhar, I.1
Dhar, A.2
Wu, L.3
Desai, K.M.4
-
64
-
-
23344435471
-
Vascular methylglyoxal metabolism and the development of hypertension
-
Wang X, Desai K, Chang T, Wu L. Vascular methylglyoxal metabolism and the development of hypertension. J Hypertens 2005;23(8):1565-1573.
-
(2005)
J Hypertens
, vol.23
, Issue.8
, pp. 1565-1573
-
-
Wang, X.1
Desai, K.2
Chang, T.3
Wu, L.4
-
65
-
-
40449113838
-
Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats
-
Wang X, Jia X, Chang T, Desai K, Wu L. Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats. J Hypertens 2008;26(4):765-772.
-
(2008)
J Hypertens
, vol.26
, Issue.4
, pp. 765-772
-
-
Wang, X.1
Jia, X.2
Chang, T.3
Desai, K.4
Wu, L.5
-
66
-
-
84926464959
-
High glucose, glucose fluctuation and carbonyl stress enhance brain microvascular endothelial barrier dysfunction: Implications for diabetic cerebral microvasculature
-
Li W, Maloney RE, Aw TY. High glucose, glucose fluctuation and carbonyl stress enhance brain microvascular endothelial barrier dysfunction: Implications for diabetic cerebral microvasculature. Redox Biol 2015;5:80-90.
-
(2015)
Redox Biol
, vol.5
, pp. 80-90
-
-
Li, W.1
Maloney, R.E.2
Aw, T.Y.3
-
67
-
-
0030597071
-
Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease
-
Castellani R, Smith MA, Richey PL, Perry G. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res 1996;737(1-2):195-200.
-
(1996)
Brain Res
, vol.737
, Issue.1-2
, pp. 195-200
-
-
Castellani, R.1
Smith, M.A.2
Richey, P.L.3
Perry, G.4
-
68
-
-
24644514279
-
Evidence of oxidative stress in the neocortex in incidental Lewy body disease
-
Dalfo E, Portero-Otin M, Ayala V, Martinez A, Pamplona R, Ferrer I. Evidence of oxidative stress in the neocortex in incidental Lewy body disease. J Neuropathol Exp Neurol 2005;64(9):816-830.
-
(2005)
J Neuropathol Exp Neurol
, vol.64
, Issue.9
, pp. 816-830
-
-
Dalfo, E.1
Portero-Otin, M.2
Ayala, V.3
Martinez, A.4
Pamplona, R.5
Ferrer, I.6
-
69
-
-
0034468706
-
Crosslinking of alpha-synuclein by advanced glycation endproducts-an early pathophysiological step in Lewy body formation?
-
Munch G, Luth HJ, Wong A, et al. Crosslinking of alpha-synuclein by advanced glycation endproducts-an early pathophysiological step in Lewy body formation? J Chem Neuroanat 2000;20(3-4):253-257.
-
(2000)
J Chem Neuroanat
, vol.20
, Issue.3-4
, pp. 253-257
-
-
Munch, G.1
Luth, H.J.2
Wong, A.3
-
70
-
-
77957109627
-
N(varepsilon)-(carboxymethyl)lysine linkage to alpha-synuclein and involvement of advanced glycation end products in alpha-synuclein deposits in an MPTP-intoxicated mouse model
-
Choi YG, Lim S. N(varepsilon)-(carboxymethyl)lysine linkage to alpha-synuclein and involvement of advanced glycation end products in alpha-synuclein deposits in an MPTP-intoxicated mouse model. Biochimie 2010;92(10):1379-1386.
-
(2010)
Biochimie
, vol.92
, Issue.10
, pp. 1379-1386
-
-
Choi, Y.G.1
Lim, S.2
-
71
-
-
48249103154
-
Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation
-
Shaikh S, Nicholson LF. Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation. J Neurosci Res 2008;86(9):2071-2082.
-
(2008)
J Neurosci Res
, vol.86
, Issue.9
, pp. 2071-2082
-
-
Shaikh, S.1
Nicholson, L.F.2
-
72
-
-
59349088294
-
The modification of alpha-synuclein by dicarbonyl compounds inhibits its fibril-forming process
-
Lee D, Park CW, Paik SR, Choi KY. The modification of alpha-synuclein by dicarbonyl compounds inhibits its fibril-forming process. Biochim Biophys Act 2009;1794(3):421-430.
-
(2009)
Biochim Biophys Act
, vol.1794
, Issue.3
, pp. 421-430
-
-
Lee, D.1
Park, C.W.2
Paik, S.R.3
Choi, K.Y.4
-
73
-
-
84885468645
-
Recent advances in alpha-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease
-
Guerrero E, Vasudevaraju P, Hegde ML, Britton GB, Rao KS. Recent advances in alpha-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease. Mol Neurobiol 2013;47(2):525-536.
-
(2013)
Mol Neurobiol
, vol.47
, Issue.2
, pp. 525-536
-
-
Guerrero, E.1
Vasudevaraju, P.2
Hegde, M.L.3
Britton, G.B.4
Rao, K.S.5
-
74
-
-
77953408910
-
Drug Targeting of alpha-Synuclein Oligomerization in Synucleinopathies
-
Outeiro TF, Kazantsev A. Drug Targeting of alpha-Synuclein Oligomerization in Synucleinopathies. Perspect Medic Chem 2008;2:41-49.
-
(2008)
Perspect Medic Chem
, vol.2
, pp. 41-49
-
-
Outeiro, T.F.1
Kazantsev, A.2
-
75
-
-
44849125207
-
Formation of toxic oligomeric alpha-synuclein species in living cells
-
Outeiro TF, Putcha P, Tetzlaff JE, et al. Formation of toxic oligomeric alpha-synuclein species in living cells. PLoS One 2008;3(4):e1867.
-
(2008)
PLoS One
, vol.3
, Issue.4
, pp. e1867
-
-
Outeiro, T.F.1
Putcha, P.2
Tetzlaff, J.E.3
-
76
-
-
79952742454
-
In vivo demonstration that alpha-synuclein oligomers are toxic
-
Winner B, Jappelli R, Maji SK, et al. In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci U S A 2011;108(10):4194-4199.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, Issue.10
, pp. 4194-4199
-
-
Winner, B.1
Jappelli, R.2
Maji, S.K.3
-
77
-
-
79951581055
-
Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress
-
Kurz A, Rabbani N, Walter M, et al. Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress. Cell Mol Life Sci 2011;68(4):721-733.
-
(2011)
Cell Mol Life Sci
, vol.68
, Issue.4
, pp. 721-733
-
-
Kurz, A.1
Rabbani, N.2
Walter, M.3
-
78
-
-
4244040278
-
Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors
-
Thornalley PJ. Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors. Chem Biol Inter 1998;111-112:137-151.
-
(1998)
Chem Biol Inter
, vol.111
, Issue.112
, pp. 137-151
-
-
Thornalley, P.J.1
-
79
-
-
0027185713
-
Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease
-
Jenner P. Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease. Act Neurol Scand Suppl 1993;146:6-13.
-
(1993)
Act Neurol Scand Suppl
, vol.146
, pp. 6-13
-
-
Jenner, P.1
-
80
-
-
0028075410
-
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
-
Sian J, Dexter DT, Lees AJ, et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 1994;36(3):348-355.
-
(1994)
Ann Neurol
, vol.36
, Issue.3
, pp. 348-355
-
-
Sian, J.1
Dexter, D.T.2
Lees, A.J.3
-
81
-
-
33646482095
-
Age-dependent changes of glyoxalase I expression in human brain
-
Kuhla B, Boeck K, Luth HJ, et al. Age-dependent changes of glyoxalase I expression in human brain. Neurobiol Aging 2006;27(6):815-822.
-
(2006)
Neurobiol Aging
, vol.27
, Issue.6
, pp. 815-822
-
-
Kuhla, B.1
Boeck, K.2
Luth, H.J.3
-
82
-
-
33745140532
-
Proteasome dysfunction in aged human alpha-synuclein transgenic mice
-
Chen L, Thiruchelvam MJ, Madura K, Richfield EK. Proteasome dysfunction in aged human alpha-synuclein transgenic mice. Neurobiol Dis 2006;23(1):120-126.
-
(2006)
Neurobiol Dis
, vol.23
, Issue.1
, pp. 120-126
-
-
Chen, L.1
Thiruchelvam, M.J.2
Madura, K.3
Richfield, E.K.4
-
83
-
-
0035870881
-
Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis
-
Tanaka Y, Engelender S, Igarashi S, et al. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet 2001;10(9):919-926.
-
(2001)
Hum Mol Genet
, vol.10
, Issue.9
, pp. 919-926
-
-
Tanaka, Y.1
Engelender, S.2
Igarashi, S.3
-
84
-
-
84863518914
-
DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway
-
Im JY, Lee KW, Woo JM, Junn E, Mouradian MM. DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway. Hum Mol Genet 2012;21(13):3013-3024.
-
(2012)
Hum Mol Genet
, vol.21
, Issue.13
, pp. 3013-3024
-
-
Im, J.Y.1
Lee, K.W.2
Woo, J.M.3
Junn, E.4
Mouradian, M.M.5
-
85
-
-
84858307371
-
Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation
-
Xue M, Rabbani N, Momiji H, et al. Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation. Biochem J 2012;443(1):213-222.
-
(2012)
Biochem J
, vol.443
, Issue.1
, pp. 213-222
-
-
Xue, M.1
Rabbani, N.2
Momiji, H.3
-
86
-
-
84864021706
-
Human DJ-1 and its homologs are novel glyoxalases
-
Lee JY, Song J, Kwon K, et al. Human DJ-1 and its homologs are novel glyoxalases. Hum Mol Genet 2012;21(14):3215-3225.
-
(2012)
Hum Mol Genet
, vol.21
, Issue.14
, pp. 3215-3225
-
-
Lee, J.Y.1
Song, J.2
Kwon, K.3
-
87
-
-
84922264295
-
Parkinsonism-associated protein DJ-1/Park7 is a major protein deglycase that repairs methylglyoxal- and glyoxal-glycated cysteine, arginine, and lysine residues
-
Richarme G, Mihoub M, Dairou J, Bui LC, Leger T, Lamouri A. Parkinsonism-associated protein DJ-1/Park7 is a major protein deglycase that repairs methylglyoxal- and glyoxal-glycated cysteine, arginine, and lysine residues. J Biol Chem 2015;290(3):1885-1897.
-
(2015)
J Biol Chem
, vol.290
, Issue.3
, pp. 1885-1897
-
-
Richarme, G.1
Mihoub, M.2
Dairou, J.3
Bui, L.C.4
Leger, T.5
Lamouri, A.6
-
88
-
-
0037454697
-
Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes
-
Beisswenger PJ, Howell SK, Smith K, Szwergold BS. Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes. Biochim Biophys Act 2003;1637(1):98-106.
-
(2003)
Biochim Biophys Act
, vol.1637
, Issue.1
, pp. 98-106
-
-
Beisswenger, P.J.1
Howell, S.K.2
Smith, K.3
Szwergold, B.S.4
-
89
-
-
84942600616
-
Genetic variants in GAPDH confer susceptibility to sporadic Parkinson's disease in a Chinese Han population
-
Liu L, Xiong N, Zhang P, et al. Genetic variants in GAPDH confer susceptibility to sporadic Parkinson's disease in a Chinese Han population. PLoS One 2015;10(8):e0135425.
-
(2015)
PLoS One
, vol.10
, Issue.8
, pp. e0135425
-
-
Liu, L.1
Xiong, N.2
Zhang, P.3
-
90
-
-
84863423974
-
Occurrence and distribution of salsolinol-like compound, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (ADTIQ) in parkinsonian brains
-
Deng Y, Zhang Y, Li Y, et al. Occurrence and distribution of salsolinol-like compound, 1-acetyl-6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline (ADTIQ) in parkinsonian brains. J Neural Transm 2012;119(4):435-441.
-
(2012)
J Neural Transm
, vol.119
, Issue.4
, pp. 435-441
-
-
Deng, Y.1
Zhang, Y.2
Li, Y.3
-
91
-
-
84893826232
-
Formation of a salsolinol-like compound, the neurotoxin, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, in a cellular model of hyperglycemia and a rat model of diabetes
-
Song DW, Xin N, Xie BJ, et al. Formation of a salsolinol-like compound, the neurotoxin, 1-acetyl-6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline, in a cellular model of hyperglycemia and a rat model of diabetes. Int J Mol Med 2014;33(3):736-742.
-
(2014)
Int J Mol Med
, vol.33
, Issue.3
, pp. 736-742
-
-
Song, D.W.1
Xin, N.2
Xie, B.J.3
-
92
-
-
84931331883
-
A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease
-
Xie B, Lin F, Ullah K, et al. A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease. Biochem Biophys Res Commun 2015;459(3):361-366.
-
(2015)
Biochem Biophys Res Commun
, vol.459
, Issue.3
, pp. 361-366
-
-
Xie, B.1
Lin, F.2
Ullah, K.3
-
93
-
-
84874455392
-
Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship
-
Vagelatos NT, Eslick GD. Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev 2013;35:152-160.
-
(2013)
Epidemiol Rev
, vol.35
, pp. 152-160
-
-
Vagelatos, N.T.1
Eslick, G.D.2
-
94
-
-
33644553117
-
Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus
-
Biessels GJ, De Leeuw FE, Lindeboom J, Barkhof F, Scheltens P. Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus. J Neurol Neurosurg Psychiatry 2006;77(3):304-307.
-
(2006)
J Neurol Neurosurg Psychiatry
, vol.77
, Issue.3
, pp. 304-307
-
-
Biessels, G.J.1
De Leeuw, F.E.2
Lindeboom, J.3
Barkhof, F.4
Scheltens, P.5
-
95
-
-
71349085957
-
Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
-
Moloney AM, Griffin RJ, Timmons S, O'Connor R, Ravid R, O'Neill C. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging 2010;31(2):224-243.
-
(2010)
Neurobiol Aging
, vol.31
, Issue.2
, pp. 224-243
-
-
Moloney, A.M.1
Griffin, R.J.2
Timmons, S.3
O'Connor, R.4
Ravid, R.5
O'Neill, C.6
-
96
-
-
1842785174
-
Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus
-
Trudeau F, Gagnon S, Massicotte G. Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus. Eur J Pharmacol 2004;490(1-3):177-186.
-
(2004)
Eur J Pharmacol
, vol.490
, Issue.1-3
, pp. 177-186
-
-
Trudeau, F.1
Gagnon, S.2
Massicotte, G.3
-
97
-
-
84855613853
-
Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial
-
Craft S, Baker LD, Montine TJ, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 2012;69(1):29-38.
-
(2012)
Arch Neurol
, vol.69
, Issue.1
, pp. 29-38
-
-
Craft, S.1
Baker, L.D.2
Montine, T.J.3
-
98
-
-
84860599622
-
Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities
-
Carvalho C, Cardoso S, Correia SC, et al. Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities. Diabetes 2012;61(5):1234-1242.
-
(2012)
Diabetes
, vol.61
, Issue.5
, pp. 1234-1242
-
-
Carvalho, C.1
Cardoso, S.2
Correia, S.C.3
-
99
-
-
0028363366
-
Advanced glycation end products contribute to amyloidosis in Alzheimer disease
-
Vitek MP, Bhattacharya K, Glendening JM, et al. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci U S A 1994;91(11):4766-4770.
-
(1994)
Proc Natl Acad Sci U S A
, vol.91
, Issue.11
, pp. 4766-4770
-
-
Vitek, M.P.1
Bhattacharya, K.2
Glendening, J.M.3
-
100
-
-
0028233977
-
Advanced Maillard reaction end products are associated with Alzheimer disease pathology
-
Smith MA, Taneda S, Richey PL, et al. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci U S A 1994;91(12):5710-5714.
-
(1994)
Proc Natl Acad Sci U S A
, vol.91
, Issue.12
, pp. 5710-5714
-
-
Smith, M.A.1
Taneda, S.2
Richey, P.L.3
-
101
-
-
17744380261
-
Albumin antioxidant capacity is modified by methylglyoxal
-
Faure P, Troncy L, Lecomte M, et al. Albumin antioxidant capacity is modified by methylglyoxal. Diabetes Metab 2005;31(2):169-177.
-
(2005)
Diabetes Metab
, vol.31
, Issue.2
, pp. 169-177
-
-
Faure, P.1
Troncy, L.2
Lecomte, M.3
-
102
-
-
0028959714
-
Are advanced glycation end-products associated with amyloidosis in Alzheimer's disease?
-
Kimura T, Takamatsu J, Araki N, et al. Are advanced glycation end-products associated with amyloidosis in Alzheimer's disease? Neuroreport 1995;6(6):866-868.
-
(1995)
Neuroreport
, vol.6
, Issue.6
, pp. 866-868
-
-
Kimura, T.1
Takamatsu, J.2
Araki, N.3
-
103
-
-
0029133373
-
Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain
-
Ledesma MD, Bonay P, Avila J. Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain. J Neurochem 1995;65(4):1658-1664.
-
(1995)
J Neurochem
, vol.65
, Issue.4
, pp. 1658-1664
-
-
Ledesma, M.D.1
Bonay, P.2
Avila, J.3
-
104
-
-
33750899858
-
Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis
-
Chen K, Maley J, Yu PH. Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis. J Neurochem 2006;99(5):1413-1424.
-
(2006)
J Neurochem
, vol.99
, Issue.5
, pp. 1413-1424
-
-
Chen, K.1
Maley, J.2
Yu, P.H.3
-
105
-
-
0028065142
-
Analysis of microtubule-associated protein tau glycation in paired helical filaments
-
Ledesma MD, Bonay P, Colaco C, Avila J. Analysis of microtubule-associated protein tau glycation in paired helical filaments. J Biol Chem 1994;269(34):21614-21619.
-
(1994)
J Biol Chem
, vol.269
, Issue.34
, pp. 21614-21619
-
-
Ledesma, M.D.1
Bonay, P.2
Colaco, C.3
Avila, J.4
-
106
-
-
0042207369
-
Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide
-
Munch G, Mayer S, Michaelis J, et al. Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide. Biochim Biophys Act 1997;1360(1):17-29.
-
(1997)
Biochim Biophys Act
, vol.1360
, Issue.1
, pp. 17-29
-
-
Munch, G.1
Mayer, S.2
Michaelis, J.3
-
107
-
-
9644273963
-
Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro
-
Necula M, Kuret J. Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro. J Biol Chem 2004;279(48):49694-49703.
-
(2004)
J Biol Chem
, vol.279
, Issue.48
, pp. 49694-49703
-
-
Necula, M.1
Kuret, J.2
-
108
-
-
0346504002
-
Advanced glycation endproduct precursor alters intracellular amyloid-beta/A beta PP carboxy-terminal fragment aggregation and cytotoxicity
-
Woltjer RL, Maezawa I, Ou JJ, Montine KS, Montine TJ. Advanced glycation endproduct precursor alters intracellular amyloid-beta/A beta PP carboxy-terminal fragment aggregation and cytotoxicity. J Alzheimers Dis 2003;5(6):467-476.
-
(2003)
J Alzheimers Dis
, vol.5
, Issue.6
, pp. 467-476
-
-
Woltjer, R.L.1
Maezawa, I.2
Ou, J.J.3
Montine, K.S.4
Montine, T.J.5
-
109
-
-
77954142794
-
Advanced glycation end products enhance amyloid precursor protein expression by inducing reactive oxygen species
-
Ko SY, Lin YP, Lin YS, Chang SS. Advanced glycation end products enhance amyloid precursor protein expression by inducing reactive oxygen species. Free Radic Biol Med 2010;49(3):474-480.
-
(2010)
Free Radic Biol Med
, vol.49
, Issue.3
, pp. 474-480
-
-
Ko, S.Y.1
Lin, Y.P.2
Lin, Y.S.3
Chang, S.S.4
-
110
-
-
12244312488
-
Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells
-
Liu BF, Miyata S, Hirota Y, et al. Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells. Kidney Int 2003;63(3):947-957.
-
(2003)
Kidney Int
, vol.63
, Issue.3
, pp. 947-957
-
-
Liu, B.F.1
Miyata, S.2
Hirota, Y.3
-
111
-
-
0034067992
-
Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta
-
Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J Neurochem 2000;74(4):1587-1595.
-
(2000)
J Neurochem
, vol.74
, Issue.4
, pp. 1587-1595
-
-
Reynolds, C.H.1
Betts, J.C.2
Blackstock, W.P.3
Nebreda, A.R.4
Anderton, B.H.5
-
112
-
-
0033782845
-
Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease
-
Zhu X, Rottkamp CA, Boux H, Takeda A, Perry G, Smith MA. Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J Neuropathol Exp Neurol 2000;59(10):880-888.
-
(2000)
J Neuropathol Exp Neurol
, vol.59
, Issue.10
, pp. 880-888
-
-
Zhu, X.1
Rottkamp, C.A.2
Boux, H.3
Takeda, A.4
Perry, G.5
Smith, M.A.6
-
113
-
-
12144278195
-
Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains
-
Luth HJ, Ogunlade V, Kuhla B, et al. Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains. Cereb Cortex 2005;15(2):211-220.
-
(2005)
Cereb Cortex
, vol.15
, Issue.2
, pp. 211-220
-
-
Luth, H.J.1
Ogunlade, V.2
Kuhla, B.3
-
114
-
-
13244270042
-
Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment
-
Ahmed N, Ahmed U, Thornalley PJ, Hager K, Fleischer G, Munch G. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment. J Neurochem 2005;92(2):255-263.
-
(2005)
J Neurochem
, vol.92
, Issue.2
, pp. 255-263
-
-
Ahmed, N.1
Ahmed, U.2
Thornalley, P.J.3
Hager, K.4
Fleischer, G.5
Munch, G.6
-
115
-
-
0037332634
-
Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia
-
Bar KJ, Franke S, Wenda B, et al. Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia. Neurobiol Aging 2003;24(2):333-338.
-
(2003)
Neurobiol Aging
, vol.24
, Issue.2
, pp. 333-338
-
-
Bar, K.J.1
Franke, S.2
Wenda, B.3
-
116
-
-
0034992635
-
Increased protein glycation in cerebrospinal fluid of Alzheimer's disease
-
Shuvaev VV, Laffont I, Serot JM, Fujii J, Taniguchi N, Siest G. Increased protein glycation in cerebrospinal fluid of Alzheimer's disease. Neurobiol Aging 2001;22(3):397-402.
-
(2001)
Neurobiol Aging
, vol.22
, Issue.3
, pp. 397-402
-
-
Shuvaev, V.V.1
Laffont, I.2
Serot, J.M.3
Fujii, J.4
Taniguchi, N.5
Siest, G.6
-
117
-
-
84879640156
-
Glycation exacerbates the neuronal toxicity of beta-amyloid
-
Li XH, Du LL, Cheng XS, et al. Glycation exacerbates the neuronal toxicity of beta-amyloid. Cell Death Dis 2013;4:e673.
-
(2013)
Cell Death Dis
, vol.4
, pp. e673
-
-
Li, X.H.1
Du, L.L.2
Cheng, X.S.3
-
118
-
-
79551490365
-
Metformin has adenosine-monophosphate activated protein kinase (AMPK)-independent effects on LPS-stimulated rat primary microglial cultures
-
Labuzek K, Liber S, Gabryel B, Okopien B. Metformin has adenosine-monophosphate activated protein kinase (AMPK)-independent effects on LPS-stimulated rat primary microglial cultures. Pharmacol Rep 2010;62(5):827-848.
-
(2010)
Pharmacol Rep
, vol.62
, Issue.5
, pp. 827-848
-
-
Labuzek, K.1
Liber, S.2
Gabryel, B.3
Okopien, B.4
-
119
-
-
79551493930
-
Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide
-
Labuzek K, Suchy D, Gabryel B, Bielecka A, Liber S, Okopien B. Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide. Pharmacol Rep 2010;62(5):956-965.
-
(2010)
Pharmacol Rep
, vol.62
, Issue.5
, pp. 956-965
-
-
Labuzek, K.1
Suchy, D.2
Gabryel, B.3
Bielecka, A.4
Liber, S.5
Okopien, B.6
-
120
-
-
84862199583
-
Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
-
Wahlqvist ML, Lee MS, Hsu CC, Chuang SY, Lee JT, Tsai HN. Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort. Parkinsonism Relat Disord 2012;18(6):753-758.
-
(2012)
Parkinsonism Relat Disord
, vol.18
, Issue.6
, pp. 753-758
-
-
Wahlqvist, M.L.1
Lee, M.S.2
Hsu, C.C.3
Chuang, S.Y.4
Lee, J.T.5
Tsai, H.N.6
-
121
-
-
79956277464
-
Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin
-
Hsu CC, Wahlqvist ML, Lee MS, Tsai HN. Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. J Alzheimers Dis 2011;24(3):485-493.
-
(2011)
J Alzheimers Dis
, vol.24
, Issue.3
, pp. 485-493
-
-
Hsu, C.C.1
Wahlqvist, M.L.2
Lee, M.S.3
Tsai, H.N.4
-
122
-
-
78650746798
-
Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling
-
Kickstein E, Krauss S, Thornhill P, et al. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling. Proc Natl Acad Sci U S A 2010;107(50):21830-21835.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, Issue.50
, pp. 21830-21835
-
-
Kickstein, E.1
Krauss, S.2
Thornhill, P.3
-
123
-
-
79952439187
-
Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes
-
Gupta A, Bisht B, Dey CS. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes. Neuropharmacology 2011;60(6):910-920.
-
(2011)
Neuropharmacology
, vol.60
, Issue.6
, pp. 910-920
-
-
Gupta, A.1
Bisht, B.2
Dey, C.S.3
-
124
-
-
84907032242
-
Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice
-
Patil SP, Jain PD, Ghumatkar PJ, Tambe R, Sathaye S. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice. Neuroscience 2014;277:747-754.
-
(2014)
Neuroscience
, vol.277
, pp. 747-754
-
-
Patil, S.P.1
Jain, P.D.2
Ghumatkar, P.J.3
Tambe, R.4
Sathaye, S.5
-
125
-
-
17944398255
-
Metformin inhibition of glycation processes
-
Beisswenger P, Ruggiero-Lopez D. Metformin inhibition of glycation processes. Diabetes Metab 2003;29(4 Pt 2):6S95-103.
-
(2003)
Diabetes Metab
, vol.29
, Issue.4
, pp. 6S95-6103
-
-
Beisswenger, P.1
Ruggiero-Lopez, D.2
-
126
-
-
84869498086
-
Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression
-
Ishibashi Y, Matsui T, Takeuchi M, Yamagishi S. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression. Hormone Metab Res 2012;44(12):891-895.
-
(2012)
Hormone Metab Res
, vol.44
, Issue.12
, pp. 891-895
-
-
Ishibashi, Y.1
Matsui, T.2
Takeuchi, M.3
Yamagishi, S.4
-
127
-
-
46749116766
-
Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells
-
Schurman L, McCarthy AD, Sedlinsky C, et al. Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells. Exp Clin Endocrinol Diabetes 2008;116(6):333-340.
-
(2008)
Exp Clin Endocrinol Diabetes
, vol.116
, Issue.6
, pp. 333-340
-
-
Schurman, L.1
McCarthy, A.D.2
Sedlinsky, C.3
-
128
-
-
84873403513
-
An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes
-
Puddu A, Mach F, Nencioni A, Viviani GL, Montecucco F. An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes. Mediators Inflamm 2013;2013:591056.
-
(2013)
Mediators Inflamm
, vol.2013
, pp. 591056
-
-
Puddu, A.1
Mach, F.2
Nencioni, A.3
Viviani, G.L.4
Montecucco, F.5
-
129
-
-
70349334516
-
Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease
-
Kim S, Moon M, Park S. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease. J Endocrinol 2009;202(3):431-439.
-
(2009)
J Endocrinol
, vol.202
, Issue.3
, pp. 431-439
-
-
Kim, S.1
Moon, M.2
Park, S.3
-
130
-
-
59049087723
-
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and parkinsonism
-
Li Y, Perry T, Kindy MS, et al. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and parkinsonism. Proc Natl Acad Sci U S A 2009;106(4):1285-1290.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, Issue.4
, pp. 1285-1290
-
-
Li, Y.1
Perry, T.2
Kindy, M.S.3
-
131
-
-
84878542289
-
Exenatide and the treatment of patients with Parkinson's disease
-
Aviles-Olmos I, Dickson J, Kefalopoulou Z, et al. Exenatide and the treatment of patients with Parkinson's disease. J Clin Invest 2013;123(6):2730-2736.
-
(2013)
J Clin Invest
, vol.123
, Issue.6
, pp. 2730-2736
-
-
Aviles-Olmos, I.1
Dickson, J.2
Kefalopoulou, Z.3
-
132
-
-
84904126994
-
Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease
-
Aviles-Olmos I, Dickson J, Kefalopoulou Z, et al. Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease. J Parkinsons Dis 2014;4(3):337-344.
-
(2014)
J Parkinsons Dis
, vol.4
, Issue.3
, pp. 337-344
-
-
Aviles-Olmos, I.1
Dickson, J.2
Kefalopoulou, Z.3
-
133
-
-
79955749452
-
The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease
-
McClean PL, Parthsarathy V, Faivre E, Holscher C. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. J Neurosci 2011;31(17):6587-6594.
-
(2011)
J Neurosci
, vol.31
, Issue.17
, pp. 6587-6594
-
-
McClean, P.L.1
Parthsarathy, V.2
Faivre, E.3
Holscher, C.4
-
134
-
-
84929302567
-
Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes
-
Xu W, Yang Y, Yuan G, Zhu W, Ma D, Hu S. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes. J Invest Med 2015;63(2):267-272.
-
(2015)
J Invest Med
, vol.63
, Issue.2
, pp. 267-272
-
-
Xu, W.1
Yang, Y.2
Yuan, G.3
Zhu, W.4
Ma, D.5
Hu, S.6
-
135
-
-
84942435321
-
Exenatide reduces TNF-alpha expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats
-
Solmaz V, Cinar BP, Yigitturk G, Cavusoglu T, Taskiran D, Erbas O. Exenatide reduces TNF-alpha expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats. Eur J Pharmacol 2015;765:482-487.
-
(2015)
Eur J Pharmacol
, vol.765
, pp. 482-487
-
-
Solmaz, V.1
Cinar, B.P.2
Yigitturk, G.3
Cavusoglu, T.4
Taskiran, D.5
Erbas, O.6
-
136
-
-
84895456459
-
Diabetes drugs and neurological disorders: new views and therapeutic possibilities
-
Patrone C, Eriksson O, Lindholm D. Diabetes drugs and neurological disorders: new views and therapeutic possibilities. Lancet Diabetes Endocrinol 2014;2(3):256-262.
-
(2014)
Lancet Diabetes Endocrinol
, vol.2
, Issue.3
, pp. 256-262
-
-
Patrone, C.1
Eriksson, O.2
Lindholm, D.3
-
137
-
-
77953880083
-
Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease
-
Holscher C. Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease. Recent Pat CNS Drug Discov 2010;5(2):109-117.
-
(2010)
Recent Pat CNS Drug Discov
, vol.5
, Issue.2
, pp. 109-117
-
-
Holscher, C.1
-
138
-
-
0032857820
-
Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II)
-
Freedman BI, Wuerth JP, Cartwright K, et al. Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II). Control Clinical Trials 1999;20(5):493-510.
-
(1999)
Control Clinical Trials
, vol.20
, Issue.5
, pp. 493-510
-
-
Freedman, B.I.1
Wuerth, J.P.2
Cartwright, K.3
-
139
-
-
84926681773
-
Recent development of plant products with anti-glycation activity: a review
-
Chinchansure AA, Korwar AM, Kulkarni MJ, Joshi SP. Recent development of plant products with anti-glycation activity: a review. RSC Advances 2015;5(39):31113-31138.
-
(2015)
RSC Advances
, vol.5
, Issue.39
, pp. 31113-31138
-
-
Chinchansure, A.A.1
Korwar, A.M.2
Kulkarni, M.J.3
Joshi, S.P.4
-
140
-
-
77950989148
-
The sour side of neurodegenerative disorders: the effects of protein glycation
-
Vicente Miranda H, Outeiro TF. The sour side of neurodegenerative disorders: the effects of protein glycation. J Pathol 2010;221(1):13-25.
-
(2010)
J Pathol
, vol.221
, Issue.1
, pp. 13-25
-
-
Vicente Miranda, H.1
Outeiro, T.F.2
|